Phreesia, Inc. (PHR) स्टॉक विश्लेषण

कंपनी का अवलोकन

Phreesia, Inc. operates as a provider of integrated software and payment platforms within the healthcare sector, specifically serving the health information services industry in the United States and Canada. The company focuses on delivering appointment scheduling systems that facilitate online bookings, reminders, and referral tracking alongside registration solutions designed to automate administrative workflows. In terms of scale, Phreesia maintains a market capitalization of $661.95M and generates annual revenue of $463.20M while employing a workforce of 2082 individuals. These financial figures indicate that the company occupies a significant position within its niche, possessing substantial revenue streams to support its operational expansion and technological development initiatives across the healthcare landscape.

वित्तीय स्वास्थ्य

The company reported a revenue of $463.20M for the trailing twelve months, yet posted a net income of -$5,379,000, revealing a cost structure where operating expenses currently outweigh profitability before interest and taxes adjustments. Despite the net loss, the entity generated an EBITDA of $14.42M, suggesting that core operational cash generation remains positive even before non-operating factors are considered. Phreesia demonstrated financial flexibility by producing free cash flow of $33.37M, which provides the liquidity necessary to fund capital expenditures and strategic investments without relying heavily on external financing. The margin profile presents a mixed picture with a gross margin of 68.2%, indicating strong pricing power or cost control in production, contrasted sharply by an operating margin of -46.7% and a profit margin of -1.2% that highlight significant overhead burdens. On the balance sheet, the company holds $439.85M in cash against $12.64M in debt, resulting in a debt-to-equity ratio of 2.60 which suggests a leveraged capital structure relative to equity holdings. Short-term liquidity is robust as evidenced by a current ratio of 2.44, indicating that current assets are more than double the current liabilities. Return on equity stands at -1.9% and return on assets is -0.3%, metrics that reveal management is currently utilizing shareholder capital and assets to generate losses rather than returns, reflecting the growth-stage nature of the business.

मूल्यांकन आकलन

Valuation metrics show a trailing P/E ratio marked as N/A due to the net loss, while the forward P/E is 7.29, implying that the market expects a significant turnaround in earnings trajectory to achieve profitability in the near future. The price-to-book ratio is 2.06, indicating that the stock trades at a premium over its book value, likely reflecting investor confidence in the company's intangible assets and future growth potential. Alternative valuation measures include a price-to-sales ratio of 1.43 and an EV/EBITDA of 16.27, which suggest the market values the company based on sales growth and operational cash flow rather than current earnings power. The stock has traded between a 52-week high of $32.76 and a 52-week low of $10.75, with the current trading position reflecting volatility within this wide range. The beta of 0.72 indicates that the stock exhibits lower price volatility relative to the broader market, moving less aggressively than the overall index during periods of market fluctuation.

Growth & Income

Revenue growth year-over-year stands at 45.7%, whereas earnings growth is N/A due to the company's current unprofitable status, implying that top-line expansion is the primary driver of business activity at this stage. As a non-dividend payer, the company does not offer a dividend yield or a payout ratio, meaning the firm retains all earnings to reinvest into research, development, and market share acquisition rather than distributing income to shareholders. The overall growth and income profile is characterized by aggressive revenue expansion funded by significant cash reserves and minimal debt obligations, prioritizing long-term market penetration over immediate income generation. This approach allows Phreesia to capitalize on high-growth opportunities in the health information services sector while building the operational efficiency required to eventually convert its strong gross margins into net profits.